Listen to this content

Psilocybin throughout history has taken on a few different connotations – from spiritual to harmful and finally to where we are today, an image of hope for treating mental and mood disorders

In recent years, studies on psychedelics and the new role that they can play in the psychiatric field, have increased tremendously.

Studies on medicinal psilocybin mushrooms have spiked in recent years

For example, The Multidisciplinary Association for Psychedelic Studies is a multimillion-dollar research group, created by Dr. Doblin, that employs 130 neuroscientists, pharmacologists, is working vigorously to lay the groundwork for what experts call the up and coming “psychedelic revolution”.

The growing interest that scientists and mental health professionals have in substances like psilocybin mushrooms, is giving new hope to the millions of people around the world today that suffer from mood disorders like depression, anxiety, and PTSD.

Universities and nations across numerous countries have set up psychedelic research centers, where investors are putting millions of dollars into medicinal psilocybin start-ups and studies.

This flood of scientific evidence has lead Canada and the United States to begin to loosen their strict anti psychedelic drug policies. 

The science behind why medical professionals are welcoming a psilocybin mushroom revolution

Today, many of the most common treatments for depression, involve pharmaceuticals that often bring heavy and unpleasant side effects.

While in contrast, microdosing psilocybin mushrooms are not addictive and cause no organ damage in even high doses, according to numerous different studies.

And when it comes to effectiveness, the results don’t lie. For example, in November 2020, a study showed that 71% of people that were suffering from major depressive disorders saw a more than 50% decrease in symptoms, after just four weeks of taking psilocybin mushrooms. And to top that off, half of the participants even enter remission.

This new evidence and support from modern-day psychiatry are helping to create a massive shift in our collective view on psychedelics’ effect on the brain – In sharp contrast to what our view used to be, just decades ago.

Psychiatry and psychedelics’ relationship in the past

Going back to before the American “war on drugs” scientists like William Richards at the Maryland Psychiatric Research, were on the verge of revolutionizing the way that we treat alcoholism and anxiety.

Science was proving that entheogens (psychoactive substances) were extremely therapeutic and have been for nearly all of human existence.

But moving on past the 1960s, people began to associate “spiritual” drugs with the counterculture movement and the use of psilocybin quickly turned political, rendering all funds for research, obsolete.

In the 1990s however, researchers began exploring again, how psychedelics affect human biology. Through the use of neuroimaging techniques both before and after volunteers used the drugs. The studies showcased how psilocybin acts on receptors for serotonin, which is a known neurotransmitter that greatly affects mood.


Today studies on the use of psilocybin for the treatment of depression, anxiety, treating addiction, and general spiritual exploration, are being heavily funded by private institutions around the world.

Millions of dollars are currently being spent on this promising new frontier, bringing hope not only to the patients that could greatly benefit but also to the mental health professionals who want nothing more than to see their patients improve.

The future – microdosing Canada and the raise of the medicinal mushroom dispensary

Several countries around the globe have hinted at the complete legalization of psilocybin mushrooms and medicinal mushroom dispensaries, painting a bright future for the use of psychedelics in medicine.

Highly respected institutions such as John Hopkins University, the Icahn School of Medicine, and the University of California have all opened research centers dedicated to further understanding just how beneficial microdosing psilocybin mushrooms can be.

What is microdosing?

Microdosing is something that will continue to be talked about more and more as the scientific community pushes forward with medicinal psilocybin advocacy.

Microdisong is the act of taking a very small, sub-hallucinogenic amount of psilocybin through mushroom capsules, in order to treat anxiety and bring one’s mind to the present.

Those that are advocates for microdosing Canada say that when following health professionals and a microdosing guide, people increase their ability to focus and improve the overall quality of their life.

Mushroom capsules can be found at many different medicinal mushroom dispensaries throughout Canada.

The fact that so many people claim to have experienced mushroom capsule benefits, proves even further just how promising psilocybin’s future really is.